REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $692 | -99.9% | 27,345 | -62.0% | 0.01% | -50.0% |
| Q2 2022 | $995,000 | +38.4% | 71,966 | +63.4% | 0.01% | +71.4% |
| Q4 2021 | $719,000 | -18.0% | 44,037 | +39.9% | 0.01% | -41.7% |
| Q3 2021 | $877,000 | -8.3% | 31,472 | -2.4% | 0.01% | +9.1% |
| Q2 2021 | $956,000 | +5.9% | 32,250 | -0.2% | 0.01% | -15.4% |
| Q1 2021 | $903,000 | +92.9% | 32,319 | +95.8% | 0.01% | +160.0% |
| Q4 2020 | $468,000 | -78.3% | 16,507 | -80.7% | 0.01% | -88.4% |
| Q3 2020 | $2,153,000 | +78.5% | 85,659 | +73.4% | 0.04% | +38.7% |
| Q2 2020 | $1,206,000 | +531.4% | 49,396 | +319.9% | 0.03% | +675.0% |
| Q4 2019 | $191,000 | – | 11,765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |